Clinical Trials Browser

Small Cell Lung Carcinoma

NCT06275360 2026-03-02

RIVAL

Carcinoma, Non-Small-Cell Lung

NCT02984761 2026-02-19

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT05179408 2026-01-27

Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer

Phase NA Recruiting

40 enrolled

Thoracic

Lung Neoplasms

NCT05467748 2026-01-27

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

Phase 1/2 Recruiting

66 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06671613 2025-11-10

Stage IV NSCLC

Phase NA Recruiting

66 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Fasting

NCT06432985 2025-09-30

CM_TUD_Cancer

Phase NA Recruiting

108 enrolled

Thoracic

Lung Neoplasms, Tobacco Use Disorder, Substance-Related Disorders

NCT05430009 2022-08-01

Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer

Phase 1 Recruiting

12 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Relapsed SCLC

RIVAL

VALOR

Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

Stage IV NSCLC

CM_TUD_Cancer

Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer